Refractory Hodgkin lymphoma: time for targeted therapies?

被引：1
|
作者：
Brice, Pauline [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BLOOD | 2018年 / 131卷 / 11期
关键词：
BRENTUXIMAB VEDOTIN; PHASE-II; SINGLE;
D O I：
10.1182/blood-2017-12-824136
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
With the use of targeted therapies in classical Hodgkin lymphoma (HL), the paradigm of salvage chemotherapy followed by autotransplant may have changed. In this issue of Blood, Herrera et al report positive results using targeted therapy for salvage treatment before autotransplantation.(1)
引用
收藏
页码：1156 / 1157
页数：4
相关论文
共 50 条
  • [1] Advances in CD30-and PD-1-targeted therapies for relapsed or refractory Hodgkin lymphoma
    Ma, Huimin
    Li, Xin
    Lin, Meng
    Lv, Kebing
    Zhang, Mingzhi
    Wu, Xiaolong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 12206 - 12216
  • [2] Targeted therapies for non-hodgkin lymphoma: Rationally designed combinations
    Martin, Peter
    Leonard, John P.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S192 - S198
  • [3] Refractory Hodgkin Lymphoma
    von Tresckow, Bastian
    Engert, Andreas
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (05) : 463 - 469
  • [4] A novel immunomodulatory and molecularly targeted strategy for refractory Hodgkin's lymphoma
    Subbiah, Vivek
    Brown, Robert E.
    McGuire, Mary F.
    Buryanek, Jamie
    Janku, Filip
    Younes, Anas
    Hong, David
    ONCOTARGET, 2014, 5 (01) : 95 - 102
  • [5] The current status and future impact of targeted therapies in non-Hodgkin lymphoma
    Ujjani, Chaitra
    Cheson, Bruce D.
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (02) : 191 - 203
  • [6] Novel therapies for Hodgkin lymphoma
    Sweetenham, John W.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2010, 1 (01) : 23 - 29
  • [7] Sequencing therapies in Hodgkin lymphoma
    Phillips, Elizabeth H.
    Collins, Graham P.
    Cwynarski, Kate
    LANCET HAEMATOLOGY, 2021, 8 (08): : E537 - E539
  • [8] Refractory or relapsed Hodgkin lymphoma
    Connors, J
    ANNALS OF ONCOLOGY, 2005, 16 : 40 - 40
  • [9] Relapsed/refractory Hodgkin lymphoma
    Sheikh, Semira
    Kuruvilla, John
    HEMASPHERE, 2018, 2 : 71 - 74
  • [10] OUTCOMES WITH NOVEL THERAPIES FOR RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A TARGETED LITERATURE REVIEW
    Shah, B.
    Furnback, W.
    Xue, M.
    Esselman, K.
    Seymour, E. K.
    Yang, K.
    VALUE IN HEALTH, 2024, 27 (06) : S397 - S397
12345